Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 132

1.

A phase 1 study of a meningococcal native outer membrane vesicle vaccine made from a group B strain with deleted lpxL1 and synX, over-expressed factor H binding protein, two PorAs and stabilized OpcA expression.

Keiser PB, Biggs-Cicatelli S, Moran EE, Schmiel DH, Pinto VB, Burden RE, Miller LB, Moon JE, Bowden RA, Cummings JF, Zollinger WD.

Vaccine. 2011 Feb 4;29(7):1413-20. doi: 10.1016/j.vaccine.2010.12.039. Epub 2011 Jan 1.

PMID:
21199704
2.

Genotypic and phenotypic correlations of multidrug-resistant Acinetobacter baumannii-A. calcoaceticus complex strains isolated from patients at the National Naval Medical Center.

Huang XZ, Frye JG, Chahine MA, Cash DM, Barber MG, Babel BS, Kasper MR, Whitman TJ, Lindler LE, Bowden RA, Nikolich MP.

J Clin Microbiol. 2010 Nov;48(11):4333-6. doi: 10.1128/JCM.01585-10. Epub 2010 Aug 25. No abstract available.

3.

Methicillin-resistant Staphylococcus aureus infection in combat support hospitals in three regions of Iraq.

Huang XZ, Cash DM, Chahine MA, Van Horn GT, Erwin DP, McKay JT, Hamilton LR, Jerke KH, Co EM, Aldous WK, Lesho EP, Lindler LE, Bowden RA, Nikolich MP.

Epidemiol Infect. 2011 Jul;139(7):994-7. doi: 10.1017/S0950268810001950. Epub 2010 Aug 23.

PMID:
20727246
4.

A novel brain heart infusion broth supports the study of common Francisella tularensis serotypes.

Mc Gann P, Rozak DA, Nikolich MP, Bowden RA, Lindler LE, Wolcott MJ, Lathigra R.

J Microbiol Methods. 2010 Feb;80(2):164-71. doi: 10.1016/j.mimet.2009.12.005. Epub 2009 Dec 11.

PMID:
20005265
5.

Rapid communication and consultation in the combat support hospital.

McKay JT, Keen EF 3rd, Bowden RA.

Mil Med. 2009 Feb;174(2):vii-x. No abstract available.

PMID:
19317186
6.

Neutrophil interactions with keratocytes during corneal epithelial wound healing: a role for CD18 integrins.

Petrescu MS, Larry CL, Bowden RA, Williams GW, Gagen D, Li Z, Smith CW, Burns AR.

Invest Ophthalmol Vis Sci. 2007 Nov;48(11):5023-9.

7.

Phase I dose escalation safety and immunogenicity trial of Plasmodium falciparum apical membrane protein (AMA-1) FMP2.1, adjuvanted with AS02A, in malaria-naïve adults at the Walter Reed Army Institute of Research.

Polhemus ME, Magill AJ, Cummings JF, Kester KE, Ockenhouse CF, Lanar DE, Dutta S, Barbosa A, Soisson L, Diggs CL, Robinson SA, Haynes JD, Stewart VA, Ware LA, Brando C, Krzych U, Bowden RA, Cohen JD, Dubois MC, Ofori-Anyinam O, De-Kock E, Ballou WR, Heppner DG Jr.

Vaccine. 2007 May 22;25(21):4203-12. Epub 2007 Mar 26.

PMID:
17442466
8.
9.

Hydroxyethyl starch inhibits neutrophil adhesion and transendothelial migration.

Handrigan MT, Burns AR, Donnachie EM, Bowden RA.

Shock. 2005 Nov;24(5):434-9.

PMID:
16247329
10.

Immunogenicity of recombinant Omp31 from Brucella melitensis in rams and serum bactericidal activity against B. ovis.

Estein SM, Cheves PC, Fiorentino MA, Cassataro J, Paolicchi FA, Bowden RA.

Vet Microbiol. 2004 Sep 8;102(3-4):203-13.

PMID:
15327795
11.
12.

Brucella lumazine synthase elicits a mixed Th1-Th2 immune response and reduces infection in mice challenged with Brucella abortus 544 independently of the adjuvant formulation used.

Velikovsky CA, Goldbaum FA, Cassataro J, Estein S, Bowden RA, Bruno L, Fossati CA, Giambartolomei GH.

Infect Immun. 2003 Oct;71(10):5750-5.

13.

Effect of interleukin-1beta and tumor necrosis factor-alpha on gene expression in human endothelial cells.

Zhao B, Stavchansky SA, Bowden RA, Bowman PD.

Am J Physiol Cell Physiol. 2003 Jun;284(6):C1577-83. Epub 2003 Jan 29.

14.

The recombinant Omp31 from Brucella melitensis alone or associated with rough lipopolysaccharide induces protection against Brucella ovis infection in BALB/c mice.

Estein SM, Cassataro J, Vizcaíno N, Zygmunt MS, Cloeckaert A, Bowden RA.

Microbes Infect. 2003 Feb;5(2):85-93.

PMID:
12650766
15.

Granulocyte transfusion therapy for infections in candidates and recipients of HPC transplantation: a comparative analysis of feasibility and outcome for community donors versus related donors.

Hübel K, Carter RA, Liles WC, Dale DC, Price TH, Bowden RA, Rowley SD, Chauncey TR, Bensinger WI, Boeckh M.

Transfusion. 2002 Nov;42(11):1414-21.

PMID:
12421213
16.

Major outer membrane proteins of Brucella spp.: past, present and future.

Cloeckaert A, Vizcaíno N, Paquet JY, Bowden RA, Elzer PH.

Vet Microbiol. 2002 Dec 20;90(1-4):229-47.

PMID:
12414146
17.

Late cytomegalovirus disease and mortality in recipients of allogeneic hematopoietic stem cell transplants: importance of viral load and T-cell immunity.

Boeckh M, Leisenring W, Riddell SR, Bowden RA, Huang ML, Myerson D, Stevens-Ayers T, Flowers ME, Cunningham T, Corey L.

Blood. 2003 Jan 15;101(2):407-14. Epub 2002 Sep 12.

18.
19.

Hyperbaric oxygen exposure temporarily reduces Mac-1 mediated functions of human neutrophils.

Kalns J, Lane J, Delgado A, Scruggs J, Ayala E, Gutierrez E, Warren D, Niemeyer D, George Wolf E, Bowden RA.

Immunol Lett. 2002 Sep 2;83(2):125-31.

PMID:
12067761
20.

Single-step purification and evaluation of recombinant BP26 protein for serological diagnosis of Brucella ovis infection in rams.

Zygmunt MS, Baucheron S, Vizcaino N, Bowden RA, Cloeckaert A.

Vet Microbiol. 2002 Jul 9;87(3):213-20.

PMID:
12052332
21.

A DNA vaccine encoding lumazine synthase from Brucella abortus induces protective immunity in BALB/c mice.

Velikovsky CA, Cassataro J, Giambartolomei GH, Goldbaum FA, Estein S, Bowden RA, Bruno L, Fossati CA, Spitz M.

Infect Immun. 2002 May;70(5):2507-11.

22.

Role of alpha4 integrin and VCAM-1 in CD18-independent neutrophil migration across mouse cardiac endothelium.

Bowden RA, Ding ZM, Donnachie EM, Petersen TK, Michael LH, Ballantyne CM, Burns AR.

Circ Res. 2002 Mar 22;90(5):562-9.

PMID:
11909820
23.

Immunogenicity of the Brucella melitensis recombinant ribosome recycling factor-homologous protein and its cDNA.

Cassataro J, Velikovsky CA, Giambartolomei GH, Estein S, Bruno L, Cloeckaert A, Bowden RA, Spitz M, Fossati CA.

Vaccine. 2002 Feb 22;20(11-12):1660-9.

PMID:
11858876
24.

Human endothelial cell response to gram-negative lipopolysaccharide assessed with cDNA microarrays.

Zhao B, Bowden RA, Stavchansky SA, Bowman PD.

Am J Physiol Cell Physiol. 2001 Nov;281(5):C1587-95.

25.

Treatment of 21 cases of invasive mucormycosis with amphotericin B colloidal dispersion.

Herbrecht R, Letscher-Bru V, Bowden RA, Kusne S, Anaissie EJ, Graybill JR, Noskin GA, Oppenheim, Andrès E, Pietrelli LA.

Eur J Clin Microbiol Infect Dis. 2001 Jul;20(7):460-6.

PMID:
11561801
26.

Randomized, placebo-controlled, double-blind study of a cytomegalovirus-specific monoclonal antibody (MSL-109) for prevention of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation.

Boeckh M, Bowden RA, Storer B, Chao NJ, Spielberger R, Tierney DK, Gallez-Hawkins G, Cunningham T, Blume KG, Levitt D, Zaia JA.

Biol Blood Marrow Transplant. 2001;7(6):343-51.

27.

Phase 1 evaluation of the respiratory syncytial virus-specific monoclonal antibody palivizumab in recipients of hematopoietic stem cell transplants.

Boeckh M, Berrey MM, Bowden RA, Crawford SW, Balsley J, Corey L.

J Infect Dis. 2001 Aug 1;184(3):350-4. Epub 2001 Jun 28.

PMID:
11443562
28.

Fungal infections in patients undergoing blood and marrow transplantation.

Marr KA, Bowden RA.

Transpl Infect Dis. 1999 Dec;1(4):237-46. Review.

PMID:
11428995
30.

Identification of protective outer membrane antigens of Brucella ovis by passive immunization of mice with monoclonal antibodies.

Bowden RA, Estein SM, Zygmunt MS, Dubray G, Cloeckaert A.

Microbes Infect. 2000 Apr;2(5):481-8.

PMID:
10865193
32.
33.

Reduced dose intravenous immunoglobulin does not decrease transplant-related complications in adults given related donor marrow allografts.

Feinstein LC, Seidel K, Jocum J, Bowden RA, Anasetti C, Deeg HJ, Flowers ME, Kansu E, Martin PJ, Nash RA, Storek J, Etzioni R, Applebaum FR, Hansen JA, Storb R, Sullivan KM.

Biol Blood Marrow Transplant. 1999;5(6):369-78.

34.

Analysis of tight junctions during neutrophil transendothelial migration.

Burns AR, Bowden RA, MacDonell SD, Walker DC, Odebunmi TO, Donnachie EM, Simon SI, Entman ML, Smith CW.

J Cell Sci. 2000 Jan;113 ( Pt 1):45-57.

35.

The population pharmacokinetics of amphotericin B colloidal dispersion in patients receiving bone marrow transplants.

Amantea MA, Bowden RA, Forrest A, Working PK, Newman MS, Mamelok RD.

Chemotherapy. 1999 Jun;45 Suppl 1:48-53.

PMID:
10394021
36.
37.
38.

P-selectin mediates neutrophil adhesion to endothelial cell borders.

Burns AR, Bowden RA, Abe Y, Walker DC, Simon SI, Entman ML, Smith CW.

J Leukoc Biol. 1999 Mar;65(3):299-306.

PMID:
10080531
39.

Comparison of six extraction techniques for isolation of DNA from filamentous fungi.

van Burik JA, Schreckhise RW, White TC, Bowden RA, Myerson D.

Med Mycol. 1998 Oct;36(5):299-303.

PMID:
10075499
41.

Rapid, transient fluconazole resistance in Candida albicans is associated with increased mRNA levels of CDR.

Marr KA, Lyons CN, Rustad TR, Bowden RA, White TC.

Antimicrob Agents Chemother. 1998 Oct;42(10):2584-9. Erratum in: Antimicrob Agents Chemother 1999 Feb;43(2):438. Rustad T [corrected to Rustad TR].

42.

Randomized, double-blind clinical trial of amphotericin B colloidal dispersion vs. amphotericin B in the empirical treatment of fever and neutropenia.

White MH, Bowden RA, Sandler ES, Graham ML, Noskin GA, Wingard JR, Goldman M, van Burik JA, McCabe A, Lin JS, Gurwith M, Miller CB.

Clin Infect Dis. 1998 Aug;27(2):296-302.

PMID:
9709879
43.

The effect of prophylactic fluconazole on the clinical spectrum of fungal diseases in bone marrow transplant recipients with special attention to hepatic candidiasis. An autopsy study of 355 patients.

van Burik JH, Leisenring W, Myerson D, Hackman RC, Shulman HM, Sale GE, Bowden RA, McDonald GB.

Medicine (Baltimore). 1998 Jul;77(4):246-54.

44.

A study of the pharmacokinetics, antiviral activity, and tolerability of oral ganciclovir for CMV prophylaxis in marrow transplantation.

Boeckh M, Zaia JA, Jung D, Skettino S, Chauncey TR, Bowden RA.

Biol Blood Marrow Transplant. 1998;4(1):13-9.

PMID:
9701387
45.

Clinical, cellular, and molecular factors that contribute to antifungal drug resistance.

White TC, Marr KA, Bowden RA.

Clin Microbiol Rev. 1998 Apr;11(2):382-402. Review.

46.

Intravenous lipid dose and incidence of bacteremia and fungemia in patients undergoing bone marrow transplantation.

Lenssen P, Bruemmer BA, Bowden RA, Gooley T, Aker SN, Mattson D.

Am J Clin Nutr. 1998 May;67(5):927-33.

PMID:
9583851
47.

Panfungal PCR assay for detection of fungal infection in human blood specimens.

Van Burik JA, Myerson D, Schreckhise RW, Bowden RA.

J Clin Microbiol. 1998 May;36(5):1169-75.

49.
50.

Supplemental Content

Loading ...
Support Center